Quarterly report · Q2
3937.TEDINET S100S6A8
Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥5.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥541m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥502m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥467m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥495m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥467m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥495m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥301m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥574m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥337m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥301m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥337m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥6.4bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥5.8bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥5.9bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.1bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.7bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.4bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥4.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.1bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.9bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.8bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.3bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥504m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥821m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥498m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥221m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥111m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥33m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥169m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥447m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥235m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥25.57 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.6 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.68 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.58 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.24 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥25.1 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥47.57 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.88 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 67.8% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.7% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 39
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-04-01 → 2023-09-30 | ¥600,000 |
| Otherother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥600,000 |
| Otherother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥300,000 |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥17m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥17m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥170m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥233m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥798m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥798m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥477m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥711m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥711m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥22m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥22m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥159m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥22m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥216m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥756m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥756m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥444m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥22m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥660m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥22m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥660m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 487
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)原 山 精 一 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)天 野 清 彦 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 2602662000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 2929925000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 5246671000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 494756000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 466626000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1004024000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 337216000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 300512000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 573793000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 465245000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 399398000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 632818000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 4088840000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 4370340000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 4090409000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 5866296000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 6448721000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 5797219000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 28.58 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 25.57 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 48.68 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 27.88 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 25.10 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 47.57 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.697 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.678 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.706 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 498060000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 503671000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 820657000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -33495000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -220653000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -110510000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -234818000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -168537000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -447488000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 3630135000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 3830227000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 3636780000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 12.24 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 16.60 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 11891440 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 11891920 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 11891440 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 11891920 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |